Summary
Onxeo SA (Onxeo) is a bio-pharmaceutical company that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company’s pipeline products include Livatag, BelCHOP, Beleodaq, AMEP, AsiDNA, Validive and others. It provides treatment of liver cancer, treatment and prevention of radio chemotherapy, head and neck cancer. Onxeo offers preclinical and clinical development, strategy and medical affairs, business development, regulatory affairs, industrial development and industrial property management. The company’s products find application in the treatment of diseases such as liver cancer, head and neck cancer, hematological cancers, solid tumors, metastatic melanoma and AIDS, among others. Onxeo is headquartered in Paris, France.
Onxeo SA (ONXEO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onxeo SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Onxeo SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Onxeo SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 10
Onxeo Enters into Agreement with Centro de Investigacion Medica Aplicada 11
Onxeo Enters into Agreement with Croix-Rousse Hospital and Centre de Recherche en Cancerologie 12
Onxeo Enters into Agreement with Synovo 13
DARA BioSciences Enters into Commercialization Agreement with Onxeo 14
Licensing Agreements 15
Pint Pharma Enters into Licensing Agreement with Onxeo for Beleodaq 15
Onxeo Enters into Licensing Agreement with Bruno Farmaceutici 16
Equity Offering 17
Onxeo Raises USD14 Million in Private Placement of Shares 17
Onxeo to Raise USD1 Million in Private Placement of Shares 19
Onxeo Raises USD51 Million in Rights Offering 21
Acquisition 23
Onxeo Acquires DNA Therapeutics 23
Onxeo SA - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Onxeo SA, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onxeo SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onxeo SA, Deals By Therapy Area, 2010 to YTD 2016 8
Onxeo SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 10
Onxeo Enters into Agreement with Centro de Investigacion Medica Aplicada 11
Onxeo Enters into Agreement with Croix-Rousse Hospital and Centre de Recherche en Cancerologie 12
Onxeo Enters into Agreement with Synovo 13
DARA BioSciences Enters into Commercialization Agreement with Onxeo 14
Pint Pharma Enters into Licensing Agreement with Onxeo for Beleodaq 15
Onxeo Enters into Licensing Agreement with Bruno Farmaceutici 16
Onxeo Raises USD14 Million in Private Placement of Shares 17
Onxeo to Raise USD1 Million in Private Placement of Shares 19
Onxeo Raises USD51 Million in Rights Offering 21
Onxeo Acquires DNA Therapeutics 23
Onxeo SA, Key Competitors 25
Onxeo SA, Key Employees 26
Onxeo SA, Subsidiaries 27
List of Figures
Onxeo SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Onxeo SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8